Ketotifen/Naphazoline Ophthalmic Solution in the Conjunctival Allergen Challenge Model of Allergic Conjunctivitis.
Completed
Bausch & Lomb Incorporated
Phase 3
2008-10-01
The purpose of this study is to establish the safety and efficacy of ketotifen/naphazoline
ophthalmic solution compared to vehicle and its individual components in alleviating the
signs and symptoms of conjunctival allergen challenge (CAC)-induced allergic conjunctivitis.
Ketotifen/Naphazoline Ophthalmic Solution in the Conjunctival Allergen Challenge Model of Acute Allergic Conjunctivitis.
Completed
Bausch & Lomb Incorporated
Phase 3
2010-02-01
The purpose of this study is to establish the safety and efficacy of ketotifen/naphazoline
ophthalmic solution compared to vehicle and its individual components in alleviating the
signs and symptoms of conjunctival allergen challenge (CAC)-induced allergic conjunctivitis.
Efficacy of Nasal Naphazoline Hydrocloride + Pheniramine Maleate + Panthenol Compared With Naphazoline Hydrocloride in the Symptomatic Control of Nasal Congestion and Nasopharyngeal
Completed
EMS
Phase 3
2013-01-01
The common cold is a major cause of nasal obstruction and reaches children and adults two or
more times a year. At the moment, there is no cure for the common cold, and therefore the
reduction of symptoms is the focus of the treatment.
The study has parallel distribution design, with two equal groups, in which one group will be
treated by a combination of naphazoline hydrocloride + pheniramine maleate + panthenol and
the other will receive treatment with naphazoline hydrocloride.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
